Molnár Csaba, Bádon Emese Sarolta, Mokánszki Attila, Mónus Anikó, Beke Lívia, Győry Ferenc, Nagy Endre, Méhes Gábor
Department of Pathology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Department of Surgery, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Diagnostics (Basel). 2020 Jan 17;10(1):48. doi: 10.3390/diagnostics10010048.
The close association between pre-existing Hashimoto's thyroiditis and thyroid cancer is well established. The simultaneous occurrence of multiple neoplastic foci within the same organ suggests a common genotoxic effect potentially contributing to carcinogenesis, the nature of which is still not clear. Next-generation sequencing (NGS) provides a potent tool to demonstrate and compare the mutational profile of the independent neoplastic foci. Our collection of 47 cases with thyroid carcinoma and Hashimoto's thyroiditis included 14 with at least two tumorous foci. Detailed histological analysis highlighted differences in histomorphology, immunoprofile, and biological characteristics. Further, a 67-gene NGS panel was applied to demonstrate the mutational diversity of the synchronic tumors. Significant differences could be detected with a wide spectrum of pathogenic gene variants involved (ranging between 5 and 18, cutoff >5.0 variant allele frequencies (VAF)). Identical gene variants represented in both synchronous tumors of the same thyroid gland were found in only two cases ( and genes). An additional set of major driver mutations was identified at variable allele frequencies in a highly individual setup suggesting a clear clonal independence. The different statuses in coincident thyroid carcinoma foci within the same organ outline a special challenge for molecular follow-up and therapeutic decision-making.
桥本甲状腺炎与甲状腺癌之间的密切关联已得到充分证实。同一器官内多个肿瘤病灶同时出现提示可能存在一种共同的基因毒性作用,这种作用可能参与致癌过程,但其本质仍不清楚。下一代测序(NGS)为展示和比较独立肿瘤病灶的突变谱提供了有力工具。我们收集的47例甲状腺癌合并桥本甲状腺炎病例中,有14例至少有两个肿瘤病灶。详细的组织学分析突出了组织形态学、免疫表型和生物学特性方面的差异。此外,应用一个包含67个基因的NGS面板来展示同步肿瘤的突变多样性。在涉及的广泛致病基因变异(范围在5到18之间,截断值>5.0变异等位基因频率(VAF))中可检测到显著差异。在同一甲状腺的两个同步肿瘤中仅发现两例存在相同的基因变异(以及 基因)。在高度个体化的情况下,以可变等位基因频率鉴定出另一组主要驱动突变,表明明显的克隆独立性。同一器官内同时存在的甲状腺癌病灶中不同的 状态给分子随访和治疗决策带来了特殊挑战。